Pfs25 is a transmission-blocking vaccine candidates. Pfs25-IMX313/Matrix-M protein-nanoparticle vaccine, is based on the Pfs25 antigen genetically fused to the IMX313 oligomerization domain and administered with Matrix-M adjuvant. The vaccine was developed by the University of Oxford